 |
The Journal of Neuroscience, September 28, 2005, 25(39):8825-8832; doi:10.1523/JNEUROSCI.0160-05.2005
Previous Article | Next Article 
Cellular/Molecular
Bradykinin-Induced Functional Competence and Trafficking of the -Opioid Receptor in Trigeminal Nociceptors
Amol M. Patwardhan,1
Kelly A. Berg,1
Armen N. Akopain,2
Nathaniel A. Jeske,2
Nikita Gamper,3
William P. Clarke,1 and
Kenneth M. Hargreaves1,2
Departments of 1Pharmacology, 2Endodontics, and 3Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229
Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the -opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK (10 µM) or vehicle, and the effects of DOR agonists ([D-Pen2,5]-enkephalin or [D-Ala2, D-Leu5]-enkephalin) on BK (10µM)/prostagladin E2 (PGE2; 1 µM)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 µM)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDORgreen fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2 receptor antagonist (HOE-140; 10µM) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1µM]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nM). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.
Key words: bradykinin; -opioid receptor; trafficking; pain; trigeminal; nociceptor
Received Jan 12, 2005;
revised August 4, 2005;
accepted August 5, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
A. C. Overland, K. F. Kitto, A.-J. Chabot-Dore, P. E. Rothwell, C. A. Fairbanks, L. S. Stone, and G. L. Wilcox
Protein Kinase C Mediates the Synergistic Interaction Between Agonists Acting at {alpha}2-Adrenergic and Delta-Opioid Receptors in Spinal Cord
J. Neurosci.,
October 21, 2009;
29(42):
13264 - 13273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bie, W. Zhu, and Z. Z. Pan
Rewarding Morphine-Induced Synaptic Function of {delta}-Opioid Receptors on Central Glutamate Synapses
J. Pharmacol. Exp. Ther.,
April 1, 2009;
329(1):
290 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.L. Gibbs and K.M. Hargreaves
Neuropeptide Y Y1 Receptor Effects on Pulpal Nociceptors
Journal of Dental Research,
October 1, 2008;
87(10):
948 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.M. Patwardhan, J. Vela, J. Farugia, K. Vela, and K.M. Hargreaves
Trigeminal Nociceptors Express Prostaglandin Receptors
Journal of Dental Research,
March 1, 2008;
87(3):
262 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Poole, J. Deuchars, D. I. Lewis, and S. A. Deuchars
Subdivision-Specific Responses of Neurons in the Nucleus of the Tractus Solitarius to Activation of Mu-Opioid Receptors in the Rat
J Neurophysiol,
November 1, 2007;
98(5):
3060 - 3071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Diogenes, A.N. Akopian, and K.M. Hargreaves
NGF Up-regulates TRPA1: Implications for Orofacial Pain
Journal of Dental Research,
June 1, 2007;
86(6):
550 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Berg, A. M. Patwardhan, T. A. Sanchez, Y. M. Silva, K. M. Hargreaves, and W. P. Clarke
Rapid Modulation of {micro}-Opioid Receptor Signaling in Primary Sensory Neurons
J. Pharmacol. Exp. Ther.,
June 1, 2007;
321(3):
839 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Ahn and A. I. Basbaum
Tissue Injury Regulates Serotonin 1D Receptor Expression: Implications for the Control of Migraine and Inflammatory Pain.
J. Neurosci.,
August 9, 2006;
26(32):
8332 - 8338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Diogenes, A. M. Patwardhan, N. A. Jeske, N. B. Ruparel, V. Goffin, A. N. Akopian, and K. M. Hargreaves
Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons
J. Neurosci.,
August 2, 2006;
26(31):
8126 - 8136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Patwardhan, N. A. Jeske, T. J. Price, N. Gamper, A. N. Akopian, and K. M. Hargreaves
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
PNAS,
July 25, 2006;
103(30):
11393 - 11398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hargreaves
Peripheral Opioid Regulation of Nociceptors. Focus on "Morphine Directly Inhibits Nociceptors in Inflamed Skin"
J Neurophysiol,
April 1, 2006;
95(4):
2031 - 2031.
[Full Text]
[PDF]
|
 |
|
|

|